Implementation of a disease trigger prediction model using AIML for early diagnosis of epilepsy

Epilepsy is one of the most prevalent neurological disorders that negatively impacts patients' quality of life and poses a severe health risk. It is often characterized by recurrent brain seizures. A current method that involves monitoring these seizures is Electroencephalography, which allows for the scientific investigation of electrical impulses within the brain. In this research, we have used Artificial Intelligence and Machine Learning in the management of Epilepsy to evaluate electrical impulses within the brain, emphasizing the potential to significantly improve the quality of life of those who suffer from this disorder. The goal of this study is to propose a Deep Neural Network model that can predict early seizure detection of Epilepsy using Electroencephalography data from a control group in order to anticipate the frequency of episodes of the patient and provide accurate insights into when they might experience their symptoms. Additionally, our research aims to identify particular genes of interest with specific protein targets that are directly responsible for the changes in EEG values in the epileptic patients. After thorough examination of these proteins' therapeutic targets and ligands, a suitable ligand and protein were identified and docked. The purpose of the docking studies in the Machine Learning model gains valuable information about the genetic origin for the change in EEG values in Epileptic patients.

The integration of predictive modeling with in-silico drug discovery enhances both the diagnostic and therapeutic dimensions of epilepsy care. This dual-layered approach not only supports early warning systems but also opens avenues for personalized treatment strategies. Our study thus represents a step toward a more holistic, computationally driven framework for neurological disorder management. By bridging data-driven seizure prediction with molecular-level therapeutic exploration, this research contributes to precision medicine and highlights the potential of interdisciplinary computational approaches in tackling complex, treatment-resistant forms of epilepsy.